Free Trial

Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Rating of "Moderate Buy" by Analysts

Bath & Body Works logo with Retail/Wholesale background

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eighteen ratings firms that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $42.00.

Several research analysts have recently commented on BBWI shares. UBS Group lifted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a research report on Monday, May 19th. Citigroup lifted their price objective on shares of Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th. Wells Fargo & Company boosted their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 14th. Finally, Raymond James Financial dropped their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th.

Get Our Latest Stock Report on BBWI

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BBWI. SVB Wealth LLC purchased a new position in shares of Bath & Body Works in the first quarter worth approximately $35,000. Geneos Wealth Management Inc. increased its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after acquiring an additional 801 shares in the last quarter. Lindbrook Capital LLC grew its position in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares in the last quarter. Parallel Advisors LLC grew its position in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock valued at $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its position in Bath & Body Works by 135.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after purchasing an additional 582 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 2.2%

BBWI stock traded up $0.73 during mid-day trading on Monday, hitting $33.68. 4,072,911 shares of the company were exchanged, compared to its average volume of 5,231,602. The company has a market capitalization of $7.13 billion, a PE ratio of 8.98, a price-to-earnings-growth ratio of 1.10 and a beta of 1.72. Bath & Body Works has a twelve month low of $24.94 and a twelve month high of $41.87. The firm has a fifty day simple moving average of $30.05 and a 200 day simple moving average of $32.59.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the previous year, the business posted $0.38 EPS. The company's quarterly revenue was up 2.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.38%. The ex-dividend date was Friday, June 6th. Bath & Body Works's dividend payout ratio (DPR) is currently 21.33%.

About Bath & Body Works

(Get Free Report

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines